In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best medical stocks to buy according to billionaires. Some experts view medical ...

Get Our Latest Research Report on ELV Elevance Health Price Performance Elevance Health stock opened at $428.62 on Thursday. The stock has a market cap of $97.03 billion, a P/E ratio of 16.74, a P ...

Elevance Health ELV has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of their ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the health insurance company to provide a report and metrics on the ...

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Healthcare ...

Elevance Health (ELV) shares rallied 5.4% in the last trading session to close at $452.69. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

In its fourth quarter 2024 investor letter, Hotchkis & Wiley Large Cap Fundamental Value Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The company’s shares closed yesterday at $435.68.